Delivery Order SPE2DR25D3202-SPE2DR26F8D7A
- Not listed
- The Defense Logistics Agency awarded a $1,030.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of August 19, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a $1,961.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with a completion date of September 4, 2025. This non-competitive delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $6,258.56 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. The contract was competitively awarded without set-aside designation on November 13, 2025, with an ultimate completion date of November 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is priced on a firm fixed-price basis and represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $2,428.65 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with a completion date of July 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a comprehensive...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,920.10 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. This firm fixed price, competitively awarded contract was issued on September 2, 2025, with a completion date of September 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $24,284.58 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of ENGERIX-B 20 MCG/ML vaccine syringes. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, was competitively awarded without a set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as one of the...
- The Defense Logistics Agency awarded a delivery order valued at $1,933.72 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This delivery order was competitively awarded with firm fixed pricing and no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $30,338.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of ENGERIX-B 20 MCG/ML vaccine syringes. The contract, which is scheduled for completion by August 7, 2025, represents a non-set-aside competitive award and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,751.90 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,343.67 delivery order for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of May 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical...
- SPE2DR25D3202Indefinite Delivery Contract
- SPE2DR25D3202-SPE2DR26F8D7ADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,837.86 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of November 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves as a prime supplier for the Defense Logistics Agency's Medical Supply Chain, delivering vaccines, specialty medications, and medical supplies to support military healthcare systems and other government agencies including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal procurement portfolio demonstrates its capability to fulfill competitive awards across a wide spectrum of pharmaceutical products and medical commodities, with previous delivery orders ranging from under $100 to over $45,000, establishing its versatility in meeting federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/17/25 |